October 18, 2017 | English | عربي
Add to Twitter
 
European Commission Approves Symtuza® for the Treatment of HIV-1 In Adults and Adolescents in Europe
Symtuza® is the only darunavir-based single-tablet regimen (STR) approved for the treatment of HIV-1 in the European Union